| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |